Better embryo genetic testing for couples without an affected child
Part of Genetic & congenital, Women’s health & pregnancy clinical trials.
This trial is testing a new, more efficient way to perform genetic testing on embryos (PGT-M) for couples who do not have a DNA sample from an affected child. It aims to help families where standard methods are difficult, such as when the carrier has no symptoms, or when the female partner has low egg reserve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a couple planning to use PGT-M (genetic testing of embryos) without having a DNA sample from an affected child (proband).
- You must have difficulty identifying the carrier parent's genetic pattern, such as: a carrier with no symptoms, healthy parents with affected children, low egg reserve in the female partner, or an X-linked condition with an extra X chromosome.
- You cannot use any other affected relative's DNA for testing.
- You are not seeking PGT-M for non-genetic reasons (non-PGT-M families).
- You are willing to consider haplotype analysis (genetic tracking) and do not insist only on direct Sanger testing of embryos.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 3 study tests whether growth hormone given during IVF can improve the chance of getting embryos with the “right” number of chromosomes, which is checked by PGT-A. It may help some people who are 38 or older planning chromosome testing of embryos.
This Phase 3 study compares two hormone/medication schedules to help women with PCOS grow embryos, then checks embryo genetic status using PGT-A. It may help determine which protocol leads to better “euploid” (chromosome-normal) blastocysts for transfer.
This study looks at embryo health using a DNA test called PGT-A for couples having IVF. It may help researchers better understand what the test can and cannot tell about which embryos are healthiest.
This trial tests whether checking embryos for extra or missing chromosomes (aneuploidy) before transfer improves IVF success for women aged 37-41. You may be eligible if you have a partner or are using donor sperm and have normal ovarian reserve.
This study looks at how well a genetic test on embryos (called PGT-M) can find specific single-gene disorders. It will help doctors learn more about these tests and improve care for families.
This study tests an upgraded method to screen embryos for genetic abnormalities before implantation during fertility treatment. It may help couples with age-related fertility concerns, repeated implantation failures, recurrent miscarriages, or male factor infertility achieve successful pregnancy.
Hear when a new Preimplantation Genetic Testing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.